Massimo Alessio

Dr. Massimo Alessio

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2002 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TATiziana Anelli
Tiziana Anelli
MAMassimo Alessio
Massimo Alessio
AMAlexandre Mezghrani
Alexandre Mezghrani
TSThomas Simmen
Thomas Simmen
FTFabio Talamo
Fabio Talamo
RSRoberto Sitia
Roberto Sitia
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 October 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TATiziana Anelli
Tiziana Anelli
MAMassimo Alessio
Massimo Alessio
ABAngela Bachi
Angela Bachi
LBLeda Bergamelli
Leda Bergamelli
GBGloria Bertoli
Gloria Bertoli
RSRoberto Sitia
Roberto Sitia
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2013 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
SIS. Iannaccone
S. Iannaccone
CCC. Cerami
C. Cerami
MAMassimo Alessio
Massimo Alessio
Valentina GaribottoValentina Garibotto
Valentina Garibotto
APA. Panzacchi
A. Panzacchi
DPD. Perani
D. Perani
Reactive microgliosis, hallmark of neuroinflammation, may contribute to neuronal degeneration, as shown in several neurodegenerative diseases. We in vivo evaluated microglia activation in early dementia with Lewy bodies, still not reported, and compared with early Parkinson's disease, to assess possible differential pathological patterns. We measured the [(11)C]-PK11195 binding potentials with Positron Emission Tomography, using a simplified reference tissue model, as marker of microglia activation, and cerebral spinal fluid protein carbonylation levels, as marker of oxidative stress. Six dementia with Lewy bodies and 6 Parkinson's disease patients within a year from the onset, and eleven healthy controls were included. Clinical diagnosis was confirmed at a 4-year follow-up. In dementia with Lewy bodies as well as in Parkinson's disease, we found significant (p < 0.001) [(11)C]-PK11195 binding potential increases in the substantia nigra and putamen. Patients with Lewy bodies dementia had extensive additional microglia activation in several associative cortices. This was evident also at a single subject level. Significant increase of Cerebral Spinal Fluid protein carbonylation was shown in both patients' groups. [(11)C]-PK11195 Positron Emission Tomography imaging revealed neuroinflammation in dementia with Lewy bodies and Parkinson's disease, mirroring, even at a single subject level, the common and the different topographical distribution of neuropathological changes, yet in the earliest stages of the disease process. Focusing on those events that characterize parkinsonisms and Parkinson's disease may be the key to further advancing the understanding of pathogenesis and to taking these mechanisms forward as a means of defining targets for neuroprotection.

15 October 1990 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Ada FunaroAda Funaro
Ada Funaro
GSG C Spagnoli
G C Spagnoli
CAC M Ausiello
C M Ausiello
MAMassimo Alessio
Massimo Alessio
SRS Roggero
S Roggero
Fabio MalavasiFabio Malavasi
Fabio Malavasi
We report clear evidence that the interaction of the CD38 molecule with the specific mAb A10 on normal human cells and lines modulates the expression of surface activation markers relevant to T, NK, and plasma cell biology and functions. Moreover A10 mAb binding is followed by proliferation effects on all the target cells analyzed, and the phenomenon is accessory cell and IL-2 dependent. The effects of A10 mAb synergizing both CD2 and CD3 activation pathways indicate that CD38 signal transduction mechanism(s) are apparently different from the aforementioned. Nevertheless the decreased A10-driven proliferation after CD3-Ti modulation suggests a possible functional interdependence between these activation pathways. Taken together, the results indicate that the CD38 molecule might play a physiologic role in T, NK, and plasma cell regulation.

15 September 2004 in The Journal of Immunology
Verified
Journal Article
Closed access
Oleksii SkorokhodOleksii Skorokhod
Oleksii Skorokhod
MAMassimo Alessio
Massimo Alessio
BMBenjamin MordmülLer
Benjamin MordmülLer
PAPaolo Arese
Paolo Arese
ESEvelin Schwarzer
Evelin Schwarzer
Acute and chronic Plasmodium falciparum malaria are accompanied by severe immunodepression possibly related to subversion of dendritic cells (DC) functionality. Phagocytosed hemozoin (malarial pigment) was shown to inhibit monocyte functions related to immunity. Hemozoin-loaded monocytes, frequently found in circulation and adherent to endothelia in malaria, may interfere with DC development and play a role in immunodepression. Hemozoin-loaded and unloaded human monocytes were differentiated in vitro to immature DC (iDC) by treatment with GM-CSF and IL-4, and to mature DC (mDC) by LPS challenge. In a second setting, hemozoin was fed to iDC further cultured to give mDC. In both settings, cells ingested large amounts of hemozoin undegraded during DC maturation. Hemozoin-fed monocytes did not apoptose but their differentiation and maturation to DC was severely impaired as shown by blunted expression of MHC class II and costimulatory molecules CD83, CD80, CD54, CD40, CD1a, and lower levels of CD83-specific mRNA in hemozoin-loaded iDC and mDC compared with unfed or latex-loaded DC. Further studies indicated activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) in hemozoin-loaded iDC and mDC, associated with increased expression of PPAR-γ mRNA, without apparent involvement of NF-κB. Moreover, expression of PPAR-γ was induced and up-regulation of CD83 was inhibited by supplementing iDC and mDC with plausible concentrations of 15(S)-hydroxyeicosatetraenoic acid, a PPAR-γ ligand abundantly produced by hemozoin via heme-catalyzed lipoperoxidation.

7 January 2011 in Journal of Proteome Research
Verified
Journal Article
Closed access
BTBarbara Tomaino
Barbara Tomaino
Paola CappelloPaola Cappello
Paola Cappello
MCMichela Capello
Michela Capello
CFClaudia Fredolini
Claudia Fredolini
ISIsabella Sperduti
Isabella Sperduti
Francesco NovelliFrancesco Novelli
Francesco Novelli